Johns Hopkins: Insurance Denials for Brand-Name Prescription Drugs Rose Sharply From 2018 to 2024
July 11, 2026
July 11, 2026
BALTIMORE, Maryland, July 11 (TNSjou) -- Johns Hopkins University Bloomberg School of Public Health issued the following news release:
* * *
Insurance Denials for Brand-Name Prescription Drugs Rose Sharply From 2018 to 2024
One in three initial fill attempts were rejected by insurers; among these, nearly half were not followed by a fill of the prescribed drug or a same-class alternative within 90 days
-
A new study led by researche . . .
* * *
Insurance Denials for Brand-Name Prescription Drugs Rose Sharply From 2018 to 2024
One in three initial fill attempts were rejected by insurers; among these, nearly half were not followed by a fill of the prescribed drug or a same-class alternative within 90 days
-
A new study led by researche . . .